Our young people of the peak-all green
Release time:
2023-05-04
du qingqing
age: 27 years old
post: Anhui xinbei card safety management department
entry time: September 2018
every job is the accumulation of experience
my hometown xiangyu town is the location of dongzhi economic development zone. in September 2018, I decided to go back to my hometown for development and entered Anhui xinbei card chemical safety and environmental protection department. When I first came into contact with the chemical industry, I had never learned about safety and environmental protection before. At that time, I was full of doubts about this job, and it was very difficult to learn. Fortunately, with the help of department leaders and colleagues, I quickly entered the working state.
When I first entered the company, there were only three people in the department. I was the only woman. I was young. The department leaders and colleagues took care of me very much. Everything at work would be explained patiently and guided carefully until I understood it. Let me feel warm. In the past five years, I have been studying every day, and with the continuous improvement of the company's safety system and the change of department leaders, I can always learn different knowledge. My first department leader took me into the door of Anhuan and gave me the opportunity to learn and practice. The second department leader taught me a rigorous and serious working attitude, allowing me to learn lessons and increase experience from every small mistake. The third leader taught me to treat every job calmly and calmly. The fourth leader taught me to sort out my thoughts before doing everything, the fifth leader taught me to establish my own "work system" and to maintain the operation of this "system"... Every day is a battle, every day is a growth, and every job is an accumulation of experience.
Now the whole society attaches great importance to safety and environmental protection. I have experienced countless inspections by governments at all levels in the past five years. The most impressive one was the one at the end of 2019. The inspection was led by the leaders of the ministries and agencies. There were also five experts and five professional safety managers. Everything from general plan, equipment, technology to fire fighting was available. The relevant personnel of our New North Card were also divided into five groups to welcome the inspection. I was in the safety management group. Before that, we made a comprehensive inspection and strict rectification in the whole factory, and experts especially praised our group at the inspection summary meeting.
In the past few years, from the preparation of emergency drill plans, to tabletop drills, to the availability of equipment and personnel in actual drills, summing up experiences and lessons after drills, and doing a good job in closed-loop management, are all my work content and "results". I am really happy to see that with the joint efforts of all the staff in the department, the messy information has become in good order, and the safety and occupational health warning signs on the production site are becoming more and more standardized.
As a full-time safety officer, the idea of "safety is no small matter, make a fuss, do all the big things" has been deeply rooted in my mind. Although I often encounter problems of one kind or another in my work, and sometimes I feel that time is not enough, I think that only by working hard to do a good job can I make continuous progress and improve myself. Thanks to the position, study and living environment provided by the company, I will continue to work conscientiously, work in a down-to-earth manner, and strive to achieve remarkable results. 19
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31